BACKGROUND: Chinese medicine distinguishes itself from Western medicine in the differentiation of diseases according to underlying patterns of disharmony, or Chinese medicine (CM) syndromes. CM has its own clinical endpoints that are used as evidence of change in the body. Yet, relatively little is known about the reliability of CM diagnostic techniques, the final diagnosis of a CM syndrome, or the organizing principles used to reach a CM diagnosis such as the Eight Guiding Principles. Information about reliability of CM diagnosis has important implications for clinical practice and research, particularly if CM diagnostic variables or CM syndromes are to be incorporated into study designs. DESIGN: An inter-rater reliability study was conducted with three CM practitioners to investigate the reproducibility of CM diagnosis according to the Eight Guiding Principles and Zang-Fu Theory. Forty-five (45) adults with mild hypercholesterolemia but who were otherwise healthy participated in the study. RESULTS: Our results suggest that there is a reasonably good level of agreement between at least two practitioners on the dimensions of the Eight Guiding Principles. Level of agreement between at least two practitioners on CM syndrome diagnosis according to Zang-Fu Theory was very good for one syndrome only, that of Spleen qi deficiency. CONCLUSIONS: Further investigations are needed into the reliability of the CM diagnostic processes from the initial stage of data collection to the final CM syndrome diagnosis.
BACKGROUND: Chinese medicine distinguishes itself from Western medicine in the differentiation of diseases according to underlying patterns of disharmony, or Chinese medicine (CM) syndromes. CM has its own clinical endpoints that are used as evidence of change in the body. Yet, relatively little is known about the reliability of CM diagnostic techniques, the final diagnosis of a CM syndrome, or the organizing principles used to reach a CM diagnosis such as the Eight Guiding Principles. Information about reliability of CM diagnosis has important implications for clinical practice and research, particularly if CM diagnostic variables or CM syndromes are to be incorporated into study designs. DESIGN: An inter-rater reliability study was conducted with three CM practitioners to investigate the reproducibility of CM diagnosis according to the Eight Guiding Principles and Zang-Fu Theory. Forty-five (45) adults with mild hypercholesterolemia but who were otherwise healthy participated in the study. RESULTS: Our results suggest that there is a reasonably good level of agreement between at least two practitioners on the dimensions of the Eight Guiding Principles. Level of agreement between at least two practitioners on CM syndrome diagnosis according to Zang-Fu Theory was very good for one syndrome only, that of Spleen qi deficiency. CONCLUSIONS: Further investigations are needed into the reliability of the CM diagnostic processes from the initial stage of data collection to the final CM syndrome diagnosis.
Authors: Eric Jacobson; Lisa Conboy; Dolma Tsering; Monica Shields; Patrick McKnight; Peter M Wayne; Rosa Schnyer Journal: J Altern Complement Med Date: 2019-11 Impact factor: 2.579
Authors: Helene M Langevin; Peter M Wayne; Hugh Macpherson; Rosa Schnyer; Ryan M Milley; Vitaly Napadow; Lixing Lao; Jongbae Park; Richard E Harris; Misha Cohen; Karen J Sherman; Aviad Haramati; Richard Hammerschlag Journal: Evid Based Complement Alternat Med Date: 2010-10-11 Impact factor: 2.629
Authors: Ingrid Jardim de Azeredo Souza Oliveira; Arthur de Sá Ferreira Journal: Evid Based Complement Alternat Med Date: 2015-04-07 Impact factor: 2.629
Authors: Ju Ah Lee; Mi Mi Ko; Jungsup Lee; Byoung-Kab Kang; Terje Alraek; Stephen Birch; Myeong Soo Lee Journal: Evid Based Complement Alternat Med Date: 2015-05-18 Impact factor: 2.629
Authors: Wendy Wong; Cindy Lo Kuen Lam; Vivian Taam Wong; Zhi Min Yang; Eric T C Ziea; Andrew Ka Lun Kwan Journal: Evid Based Complement Alternat Med Date: 2013-04-24 Impact factor: 2.629
Authors: Suzanne J Grant; Rosa N Schnyer; Dennis Hsu-Tung Chang; Paul Fahey; Alan Bensoussan Journal: Evid Based Complement Alternat Med Date: 2013-05-09 Impact factor: 2.629